SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Anglo American plc (NGLOY) , forward earnings yield 3.15%. PEG 2.22.
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($13.00, 46.8%); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 2.22).
- Forward P/E 31.7
- PEG Ratio 2.22 — above 2.0 suggests expensive relative to earnings growth.
- Analyst consensus target $13.00 (-46.8% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 32/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NGLOY
Valuation Multiples
P/E (TTM)0.0
Forward P/E31.7
PEG Ratio2.22
Forward PEG2.22
P/B Ratio0.00
P/S Ratio2.97
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.83
Forward EPS (Est.)$0.77
Book Value / Share$0.00
Revenue / Share$8.21
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield3.15%
Dividend Yield0.00%
Analyst Target$13.00 (-46.8%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.62 |
$21.38B |
$1.59B |
7.5% |
| 2017 |
$1.23 |
$26.24B |
$3.17B |
12.1% |
| 2018 |
$1.37 |
$27.61B |
$3.55B |
12.9% |
| 2019 |
$1.38 |
$29.87B |
$3.55B |
11.9% |
| 2020 |
$0.84 |
$25.45B |
$2.09B |
8.2% |
| 2021 |
$3.42 |
$41.55B |
$8.56B |
20.6% |
| 2022 |
$1.84 |
$35.12B |
$4.51B |
12.9% |
| 2023 |
$0.12 |
$30.65B |
$283M |
0.9% |
| 2024 |
$-1.26 |
$27.29B |
$-3.07B |
-11.2% |
| 2025 |
$-1.83 |
$18.58B |
$-4.14B |
-22.3% |
